Categories: News

NYSE Content Advisory: Pre-Market update + Voyager, Ategrity pop double digits in debuts

NEW YORK, June 12, 2025 /PRNewswire/ — The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today’s NYSE Pre-market update for market insights before trading begins. 

- Advertisement -

Kristen Scholer delivers the pre-market update on June 12th

- Advertisement -
  • Stocks are down fractionally this morning after the S&P 500 ended a three-day win streak yesterday. The major index is about 2% from its record.
  • Amid the market momentum, Voyager Technologies (NYSE: VOYG) and Ategrity (NYSE: ASIC) popped double digits in their debuts yesterday. Voyager is a $3.1 billion space and defense company. Ategrity is an insurer valued at about $1.2 billion.
  • NYSE-listed Oracle is seeing shares rise more than 7%. Its latest earnings exceeded expectations and it also indicated more cloud growth ahead, anticipating cloud infrastructure revenue will rise by more than 70% in the fiscal year.

Opening Bell
Ategrity (NYSE: ASIC) celebrates its listing on the NYSE

- Advertisement -

Closing Bell
Cardinal Health (NYSE: CAH) celebrates its 2025 Investor Day

- Advertisement -

Click here to download the NYSE TV App

- Advertisement -

Video – https://mma.prnewswire.com/media/2709751/NYSE_June_12_Market_Update_Voyager_Ategrity.mp4 
Logo – https://mma.prnewswire.com/media/2581322/5367565/New_York_Stock_Exchange_Logo.jpg

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/nyse-content-advisory-pre-market-update–voyager-ategrity-pop-double-digits-in-debuts-302480243.html

- Advertisement -

Recent Posts

Kia PV5 Cargo Achieves Maximum FiveStar Rating in 2025 Euro NCAP Commercial Van Safety Assessment

Kia PV5 Cargo earns the top five-star rating in the 2025 Euro NCAP Commercial Van…

2 minutes ago

Kia Launches Inspiration Connects Us All Campaign Ahead of FIFA World Cup 2026

New campaign highlights Kia’s commitment to promoting unity and connection for people around the worldKia…

2 minutes ago

Menarini Group Presents Elacestrant (ORSERDU) Phase 2 Combination Data in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2025 San Antonio Breast Cancer Symposium

In addition, the expansive elacestrant clinical development program updates reinforce its potential as a backbone endocrine…

1 hour ago

Manipal Hospitals Enhances Movement and Confidence Through Awareness on Movement Disorders

BENGALURU, India, Dec. 8, 2025 /PRNewswire/ -- Parkinson's disease often begins far more quietly than…

1 hour ago

UCB presents positive results from GEMZ phase 3 study at AES showing fenfluramine significantly reduces countable motor seizure frequency in CDKL5 Deficiency Disorder

Seizure reduction: phase 3 study achieved primary endpoint as fenfluramine demonstrated a statistically significant reduction…

1 hour ago

Investment of Approx. USD 460,000 for the Development of a Prototype Mpox Detection Test with NIPRO, TBA, Japan Institute for Health Security and others

TOKYO, Dec. 8, 2025 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today an investment…

1 hour ago